drugset / Trial / NCT00064415
To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the long-term safety of arformoterol over a period of 12 months in subjects with COPD
Timeline
- Start
- 2002-06
- Primary completion
- 2004-12
- Completion
- 2004-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Arformoterol | Small molecule | 50 ug | Inhaled |
| Comparator | Salmeterol | Other / unclassified | 42 ug | Inhaled |